Diminished Short-Term Efficacy of Reduced-Dose Induction BCG in the Treatment of Non-Muscle Invasive Bladder Cancer.

Cancers (Basel) · 2023 · PMC10377836 · PMID 37509407

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a worrying trendno p-value reported

Importantly, our results demonstrate a worrying trend of early recurrences, most within 100 days of induction therapy and identified on the first post-induction surveillance cystoscopy, among patients receiving reduced-dose induction BCG.

also in 304 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.